|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.2 TWD | -1.12% |
|
-2.86% | +9.57% |
| May. 08 | CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 07 | CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index | CI |
CH Biotech R&D Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 824.81 million compared to TWD 800.85 million a year ago. Net income was TWD 419.07 million compared to TWD 392.85 million a year ago.
Basic earnings per share from continuing operations was TWD 4.08 compared to TWD 4.05 a year ago. Diluted earnings per share from continuing operations was TWD 4.06 compared to TWD 3.96 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.57% | 281M | |
| +15.96% | 38.73B | |
| -.--% | 11.33B | |
| -4.76% | 7.5B | |
| -1.21% | 6.3B | |
| -1.68% | 5.94B | |
| -9.23% | 5.38B | |
| +29.94% | 5.13B | |
| -11.73% | 4.6B | |
| +4.21% | 3.89B |
CH BIOTECH R&D CO., LTD. 
